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Abstract
Introduction: Recent evidence suggests a link between excess lipid peroxidation and specific organ failures in
sepsis. No study has been performed in sepsis by multidrug-resistant (MDR) Gram-negative bacteria.
Methods: Lethal sepsis was induced in rats by the intraperitoneal injection of one MDR isolate of Pseudomonas
aeruginosa. Produced malondialdehyde (MDA) was measured in tissues 5 hours after bacterial challenge with the
thiobarbiturate assay followed by high-performance liquid chromatography (HPLC) analysis. Results were compared
with those from a cohort of patients with ventilator-associated pneumonia (VAP) and sepsis by MDR Gram-
negative bacteria. More precisely, serum MDA was measured on 7 consecutive days, and it was correlated with
clinical characteristics.
Results: MDA of septic rats was greater in the liver, spleen, and aortic wall, and it was lower in the right kidney
compared with sham operated-on animals. Findings were confirmed by the studied cohort. Circulating MDA was
greater in patients with hepatic dysfunction and acute respiratory distress syndrome (ARDS) compared with
patients without any organ failures. The opposite was found for patients with acute renal dysfunction. No
differences were found between patients with ARDS without or with cardiovascular (CV) failure and patients
without any organ failure. Serial measurements of MDA in serum of patients indicated that levels of MDA were
greater in survivors of hepatic dysfunction and ARDS and lower in survivors of acute renal dysfunction.
Conclusions: Animal findings and results of human sepsis are complementary, and they suggest a
compartmentalization of lipid peroxidation in systemic infections by MDR gram-negative bacteria.
Introduction
Oxidative stress results from an imbalance between pro-
duction of reactive oxygen and nitrogen species (ROS and
RNS) and endogenous antioxidant defense mechanisms
[1]. A growing body of evidence suggests that many of the
effects of cellular dysfunction under oxidative stress are
mediated by products of nonenzymatic reactions, such as
the peroxidative degradation of polyunsaturated fatty
acids. Aldehyde molecules generated during lipid peroxi-
dation are considered ultimate mediators of toxic effects
elicited by oxidative stress occurring in biologic material.
Malondialdehyde (MDA) is the most abundant lipid per-
oxidation-specific aldehyde [2].
The process of lipid peroxidation accompanied by
excess production of MDA has been well documented
both in experimental studies with cells infected by speci-
fic pathogens [3] and in systemic infections complicated
by sepsis and leading to death [4,5]. Available evidence
from studies in humans evokes the impression that lipid
peroxidation is a harmful event ubiquitously accompany-
ing all cases of systemic inflammation and sepsis to such
an extent that circulating MDA may be conceived of as a
biomarker of unfavorable prognosis [4-6]. Surprisingly, a
recent study in patients with severe sepsis (that is, sepsis
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complicated by organ failure) showed that MDA is
increased in the circulation of patients with hepatic fail-
ure and with renal failure but not in the circulation of
patients with respiratory failure and circulatory failure
[7]. These results were generated in a cohort of 50 sepsis
patients and required further confirmation. However,
they suggest that lipid peroxidation is not a ubiquitous
phenomenon, and that it may be implicated in specific
organ failures in a compartmentalized fashion.
Many cases of sepsis develop as complications of hospi-
talization in the intensive care unit (ICU). In such cases,
the offending pathogens are often multidrug resistant
(MDR), and they impose considerable difficulties in man-
agement because the available antimicrobial agents are
limited [8]. The only solution to this emerging problem
is the in-depth understanding of the pathogenesis behind
sepsis caused by MDR bacteria. At this point, it should
be underscored that the studied models of sepsis use
either purified PAMPs (pathogen-associated molecular
patterns) or peritonitis after CLP (cecal ligation and
puncture) as a stimulus. MDR bacteria are considered to
stimulate host responses in a fashion similar to that of
community-acquired susceptible bacteria. However,
much ambiguity exists whether MDR gram-negative iso-
lates possess different virulence characteristics from sus-
ceptible gram-negative isolates. This is very difficult to
conclude from a clinical study in which inappropriate
antimicrobial therapy is the driver for unfavorable out-
comes after infection with MDR bacteria and does not
allow focus on precise virulence characteristics [9]. In a
recent retrospective study, the physical course of 29
patients infected with carbapenem-resistant Enterobac-
teriaceae was compared with that of 29 well-matched
patients infected with carbapenem-susceptible Entero-
bacteriaceae; in-hospital mortalities were 30.8% and 7.4%,
respectively (P = 0.04) [10]. Similar results were drawn
from a retrospective study of our group on the outcomes
of 243 patients; however when patients with severe sepsis
were analysed separately, it was found that severe sepsis
caused by MDR bacteria was accompanied by prolonged
survival compared with severe sepsis caused by suscepti-
ble bacteria [11]. As a consequence, it may be hypothe-
sized that the pathogenesis of infections by MDR bacteria
may have specific peculiarities.
It is thus evident that in-depth understanding is
required on the process of lipid peroxidation for infec-
tions caused by MDR bacteria. This is based on (a) the
compartmentalization of the process of lipid peroxidation
for the generation of organ failures coming from one
cohort of patients with severe sepsis [7]; and (b) different
clinical characteristics of severe sepsis elicited by MDR
bacteria from those by susceptible bacteria [11]. To this
end, a dual approach was used: first, we studied lipid per-
oxidation in tissues in a lethal sepsis model with MDR
Pseudomonas aeruginosa, and then we tried to confirm
findings of circulating MDA in patients with specific
organ failures after ventilator-associated pneumonia
(VAP) from MDR gram-negative bacteria (Figure 1).
Materials and methods
Animal study
In total, 60 male Wistar rats were studied. Their mean ±
SD weight was 253.4 ± 22.4 g. The study received permis-
sion from the Veterinary Directorate of the Perfecture of
Athens, according to the Greek legislation, in conformance
to the Council Directive of the European Community. Rats
were housed in metal cages and had access to tap water
and standard balanced chow ad libitum. Temperature ran-
ged between 18°C and 22°C; relative humidity, between
55% and 65%; and the light/dark cycle was 6 AM to 6 PM.
One multidrug-resistant (MDR) isolate of P. aeruginosa
from the blood of a patient with severe sepsis was applied.
Minimal inhibitory concentrations (MICs) of piperacillin/
tazobactam, ceftazidime, imipenem, meropenem, cipro-
floxacin, and amikacin, determined with a microdilution
technique, were 256/4, 256, 128, 64, 512, and 512 μg/ml,
respectively. The isolate was stored as multiple aliquots in
skim milk (Oxoid Ltd, London, UK) under -70°C. One ali-
quot was removed from the refrigerator before each
experiment. Single colonies were incubated at 37°C in 10
ml of Mueller-Hinton broth (Oxoid Ltd) for 8 hours to
yield a log-phase inoculum that was applied for bacterial
challenge.
Animals were divided into two groups for treatment,
as follows:
• Group A (n = 15), sham-operated; injected intraperi-
toneally with 1 ml of Mueller-Hinton; and
• Group B (n = 45), animals injected intraperitoneally
with 1 ml of the prepared inoculum of the test isolate
yielding a challenge of 5 × 106 cfu/rat.
Survival was recorded at 12-hour intervals for four ani-
mals of group A and for 10 animals of group B. To iden-
tify the peak time point of lipid peroxidation, animals of
group B were killed at serial time intervals with six rats
per interval. At every time of sacrifice, a midline abdom-
inal incision was performed. Intestines were displaced to
the left, and the inferior vena cava was recognized and
punctured with a 19-gauge needle. Five milliliters of blood
was collected into pyrogen-free syringes and applied for
the measurement of tumor necrosis factor-alpha (TNF-a)
and of malondialdehyde (MDA). Animals were then killed
with an intramuscular injection of pentothal.
These experiments were repeated in six animals per
group at the defined peak time point of serum MDA.
Under sterile conditions, segments from the liver, spleen,
lower lobe of the right lung, the heart, the right kidney
and of the abdominal aorta were taken and placed into
separate sterile plastic containers. In these experiments,
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5 ml of blood was sampled after venipuncture of the
lower vena cava under aseptic conditions and collected
into EDTA-containing tubes (Becton Dickinson, Cock-
eysville, MD, USA) for the measurement with flow cyto-
metry of an oxidative burst on neutrophils. Tissue
segments were weighed and homogenized by using 1 ml
of sterile phosphate-buffered saline (PBS; pH 7.2). For
the measurement of tissue bacterial outgrowth, aliquots
of 0.1 ml of the homogenates were diluted 1:10 into ster-
ile 0.9% NaCl for four consecutive times. Aliquots of 0.1
ml of each dilution were plated onto McConkey agar and
incubated at 35°C for 3 days. The number of viable colo-
nies was counted by multiplying with the appropriate
dilution factor. The lower limit of detection was 10 cfu/g.
The number of viable cells in tissues was expressed by
log10 values.
Lipid peroxidation was estimated in serum and in tis-
sue homogenates by the concentration of MDA, as
already described [12]. In brief, a 0.1-ml aliquot of each
sample was mixed with 0.9 ml of trichloroacetic acid
20% (Merck, Darmstadt, Germany) and centrifuged at
12,000 g and 4°C for 10 minutes. The supernatant was
removed and incubated with 2 ml of thiobarbituric acid,
0.2% (Merck) for 60 minutes at 90°C. After centrifuga-
tion, a volume of 10 μl of the supernatant was injected
into a high-performance liquid chromatography system
(HPLC; Agilent 1100 Series, Waldbronn, Germany) with
the following characteristics of elution: Zorbax Eclipse
XDB-C18 (4.6 × 150 mm, 5 μm) column under 37°C;
mobile phase consisting of 50 mM K3PO4 (pH 6.8) buf-
fer, and methanol 99% at a 60:40 ratio with a flow rate
of 1 ml/min, fluorometric detection with signals of exci-
tation at 515 nm and emission at 535 nm. The retention
time of MDA was 3.5 minutes, and it was estimated in
millimoles per milliliter with a standard curve created
with 1,1,3,3-tetramethoxy-propane (Merck). All determi-
nations were performed in duplicate. The lowest limit of
detection was 0.1 mmol/ml, and the interday variation
of the assay was 1.01%. Tissue concentrations of MDA
were expressed as millimoles per gram.
Concentrations of serum TNF-a were measured in
duplicate with an enzyme immunoassay (Diaclone,
Marseille, France). The lower limit of detection was
12 pg/ml.
Figure 1 Study flow chart. MDA, malondialdehyde; MDR, multidrug resistant; VAP, ventilator-associated pneumonia. The chest radiograph is of
a patient enrolled in the study cohort, with permission.
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For the measurement of the oxidative burst on neutro-
phils, 0.1 ml of EDTA-blood was aliquoted into separate
sterile tubes. A volume of 20 μl of phorbol-myristate
(PMA, Sigma, St. Louis, MO, USA; final concentration,
10 μΜ) was added in the second tube, and the first tube
was left untreated. Both tubes were incubated for 10 min-
utes at 37°C in a water bath. Then 10 μl of DHR (dihy-
drorhodamine; Sigma, final concentration 100 μΜ) was
added. After 10 minutes of incubation at 37°C in a water
bath, 1 ml of VersaLyse was added in both tubes for the
lysis of red blood cells (Immunotech, Marseille, France).
After 15 minutes of incubation in the dark, tubes were
analyzed with the FC500 counter (Beckman Coulter,
Miami, FL, USA). Oxidative burst was expressed as the
mean fluorescence intensity (MFI) of DHR on granulo-
cytes after gating by the characteristic FS/SS scattering by
using PMA-untreated cells as negative controls.
Clinical study
Serum samples were collected daily on the first 7 days
from 93 patients enrolled in the placebo arm of a double-
blind, randomized, placebo-controlled clinical trial for the
management of VAP and sepsis [13]. The study was per-
formed during the period from June 2004 to November
2005, and patients were hospitalized in the Department of
Critical Care Medicine of the “Evangelismos” General
Hospital, in the 2nd Department of Critical Care Medicine
of the “ATTIKON” University Hospital of Athens and in
the 4th Department of Internal Medicine of the “ATTI-
KON” University Hospital of Athens. The study was con-
ducted after approval of the Ethics Committees of
Evangelismos General Hospital and of ATTIKON Univer-
sity Hospital and after written informed consent by first-
degree relatives. Patients were divided into those with
hepatic dysfunction, acute respiratory distress syndrome
(ARDS), acute renal dysfunction, and cardiovascular fail-
ure (CV) by standard definitions [14]. Three microliters of
blood was sampled for 7 consecutive days after venipunc-
ture of one forearm vein under aseptic conditions and col-
lected into pyrogen-free tubes (Vacutainer, Becton
Dickinson). The tubes were immediately centrifuged, and
serum was kept refrigerated at -70°C until assayed. Con-
centrations of MDA were measured in serum, as described
earlier.
Study end points
The primary study end point was the existence of compart-
mentalization of lipid peroxidation in relation to the speci-
fic failing organs. This was assessed in an experimental
model in rodents, and it was tested for confirmation by the
measurement of circulating MDA in patients with sepsis.
The secondary study end point was the correlation
between circulating MDA and final outcome in relation
to the underlying organ failure.
Statistical analysis
For animal experiments, survival was estimated with
Kaplan-Meier analysis. Concentrations of MDA and TNF-
a were expressed by their means ± SEM. Comparisons of
concentrations of MDA and of TNF-a in serum between
serial times of sampling were done with one-way analysis
of variance (ANOVA) with post hoc Bonferroni correc-
tions. Comparisons of tissue MDA between groups A and
B were performed with the Mann-Whitney U test. Corre-
lations between tissue MDA and bacterial growth were
according to Spearman’s rank of order.
For the clinical study, the MDA of the first day in serum
was expressed as median and 95% confidence intervals.
Comparisons between patients with organ failures and
those without any organ failures were done with the
Mann-Whitney U test, analyzing also for outliers. To
demonstrate the impact of lipid peroxidation in the patho-
genesis of liver dysfunction and of renal dysfunction, all
patients with acute hepatic dysfunction and all patients
with acute renal dysfunction were grouped together as
having hepatic dysfunction and renal dysfunction, respec-
tively, whether or not they had other organ failures.
MDAs of consecutive days were expressed as mean ±
SEM. Comparisons between survivors and nonsurvivors
were done with the Mann-Whitney U test. For all compar-
isons, any value of P < 0.05 after adjustment for multiple
comparisons with Bonferroni was considered significant.
Results
Animal infection model
Mortality of the studied sepsis model by MDR P. aerugi-
nosa was 50% at 12 hours after bacterial challenge and
100% at 36 hours after bacterial challenge. None of the
sham-operated-rats died. Sacrifice experiments conducted
at serial time intervals after bacterial challenge found the
peak of serum MDA at 5 hours (Figure 2). This coexisted
with the peak of the proinflammatory response as indexed
by serum TNF-a. Based on this finding, it was decided
that sacrifice experiments with measurement of tissue
lipid peroxidation should be repeated in rats killed at
5 hours after challenge with the test isolate.
These experiments showed that MDA was particularly
elevated in liver, in spleen, and in the aortic wall (Figure 3);
however, MDA was significantly reduced in the right kid-
ney. Paired comparisons by the Wilcoxon signed-rank test
showed that MDA in the liver was greater than that in the
lung (P = 0.016), in the spleen (P = 0.041), in the heart
(P = 0.004), but not in the aortic wall (P = 0.116). At the
time of death, tissues of sham-operated-on rats were sterile.
However, mean ± SEM counts of the injected isolate in the
liver were log10 3.95 ± 0.63 cfu/g; in the spleen, log10
4.29 ± 0.71 cfu/g; in the lung, log10 3.07 ± 0.76 cfu/g; in the
heart, log10 2.55 ± 0.58 cfu/g; and in the aortic wall, log10
3.88 ± 0.67 cfu/g. Paired comparisons did not show any
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difference between the bacterial growth of the liver com-
pared with the other tissues. No significant correlation
could be found between MDA and bacterial growth in tis-
sues (correlation for liver, rest, -0.273; P = 0.417; for lung,
rest, +0.040; P = 0.841; for spleen, rs, -0.445; P = 0.170; for
right kidney, rs, +0.080, P = 0.815; for heart, rs: -0.516, P =
0.295; and for aorta, rs: +0.123, P = 0.715; data not shown).
At the time of death, the neutrophil burst was defec-
tive in circulating neutrophils of infected rats (Figure 4).
Clinical study
Results of the animal experiments prompted us to
hypothesize that a compartmentalization of the oxidant
status takes place in sepsis. To investigate whether this
is also the situation for human sepsis, we measured
circulating MDA in 93 patients with sepsis, making the
hypothesis that serum MDA should differ between
patients as a reflection of the failing organ. These
patients were enrolled in the placebo arm of a rando-
mized trial previously published [13,15]. All had VAP,
and the pathogens isolated in the quantitative tracheo-
bronchial secretions were MDR species of Acinetobacter
baumannii, of Pseudomonas aeruginosa, and of Kleb-
siella pneumoniae. As a consequence, this study cohort
could be used to extrapolate animal findings because all
patients had the same source of sepsis (that is, VAP),
and they were infected with MDR bacteria. The demo-
graphic characteristics of these patients were described
elsewhere [13].
Analysis of circulating MDA was done in relation to
the type of failing organ. From these 93 patients, 18 did
not have any organ failure; the mean ± SEM pO2/FiO2 of
the first day of sampling of these patients was 338.9 ±
34.8 mm Hg. This pO2/FiO2 ratio showed that they did
not have acute lung injury, and they could be used as
appropriate comparators for this analysis. Another 10
patients had hepatic dysfunction, 23 had only ARDS; 25
had ARDS and CV failure; 14 had CV failure without
ARDS; and 10 had acute renal dysfunction. Of the 10
patients with acute hepatic dysfunction, four also had
other organ failures. Of the 10 patients with acute renal
dysfunction, three also had other organ failures. Circulat-
ing concentrations of MDA are shown in Figure 5. It was
obvious that circulating MDA was increased in the case
of hepatic dysfunction and in the case of ARDS. In
patients with both ARDS and CV failure or with CV fail-
ure without ARDS, MDA did not increase. Circulating
MDA was lower in patients with acute renal dysfunction
than in patients without organ failures and corroborated
the findings of the experimental infection model in rats.
Of the 93 enrolled patients, the implicated pathogen
was isolated from quantitative tracheobronchial secre-
tions at a quantity > 105 cfu/ml from 60 patients. More
precisely, Pseudomonas aeruginosa was isolated from 10
patients, Acinetobacter baumannii from 38 patients,
Klebsiella pneumoniae from six patients, and other
gram-negative species from six patients. Microbiology
documentation failed in 30 patients. Serum MDA in
relation with the microbiology of VAP is shown in
Figure 6. No differences were found in relation to the
underlying pathogen (P = 0.925).
Follow-up measurements in survivors and nonsurvivors
from organ failures are shown in Figure 7. Time-kinetics
of MDA differed in relation to the type of failing organ
(s). More precisely, serum MDA was greater in survivors
from hepatic dysfunction on day 4 and in survivors from
ARDS and CV failure on day 5. Serum MDA was also
lower on day 4 among survivors from acute renal
Figure 2 Serial concentrations of tumor-necrosis factor-a (TNF-
a) and malondialdehyde (MDA) after bacterial challenge.
Experimental sepsis was induced in rats after the intraperitoneal
injection of one multidrug-resistant isolate of Pseudomonas
aeruginosa. At the indicated time intervals after challenge (n = 6 per
time), rats were killed, and concentrations of MDA (a) and of TNF-a
(b) were measured in serum. *P < 0.05 compared with the 5-hour
interval after adjustment for multiple comparisons.
Toufekoula et al. Critical Care 2013, 17:R6
http://ccforum.com/content/17/1/R6
Page 5 of 11
dysfunction. Similar statistical comparisons could not be
done for patients with single ARDS, because the number
of nonsurvivors was low (n = 2).
No statistical correlation could be found between
serum MDA and survival time for any of these sub-
groups of patients (data not shown).
Discussion
Excess formation of lipid peroxides in serum accompa-
nied by consumption of the total antioxidant capacity of
blood has been demonstrated to take place over the
time-course of experimental bacteremia by MDR P. aer-
uginosa in rabbits [16]. In the present study, in-depth
investigation in an animal model of lethal sepsis by the
same MDR species revealed that lipid peroxidation was
highly compartmentalized. Excess formation of MDA
took place in the liver, in the spleen, and in the aortic
wall, whereas that was not the case for the lung and for
the heart. On the contrary, MDA was decreased in the
kidneys. It should be overemphasized that, at the time
of animal death, when lipid peroxidation differed con-
siderably within tissues, the oxidative burst of circulating
neutrophils was defective. This finding is in accordance
with reports that the function of neutrophils becomes
defective in severe sepsis in exactly the same way that
immunoparalysis succumbs in the constellation of infec-
tion-induced organ failures [17]. However, this finding
may also reflect, at least in part, that in the studied set-
ting of widespread systemic infection by MDR P. aerugi-
nosa, oxidative stress fails in circulating neutrophils, but
it is highly generated in tissues, probably as a result of
infiltration by neutrophils.
These findings corroborate many of the findings of
other investigators, but they also present discrepancies
with other studies in rodents. In these studies, investiga-
tors used either purified bacterial lipopolysaccharide
(LPS) or CLP to stimulate host defenses. MDA in liver
homogenates had been increased in rats killed 6 hours
Figure 3 Tissue concentrations of MDA after bacterial challenge. Experimental sepsis was induced in rats after the intraperitoneal injection
of 2 × 107 cfu/animal of one multidrug-resistant isolate of Pseudomonas aeruginosa. Five hours after challenge (n = 6 per group), rats were
killed, and concentrations of malondialdehyde (MDA) were measured in the tissue homogenates of liver (a), lung (b), spleen (c), right kidney (d),
heart (e), and aorta (f). P values compared with sham-operated rats are shown.
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after the intraperitoneal injection of LPS [18]. When a
model of CLP was studied in rats, downregulation of the
expression of genes coupled with mitochondrial function
was found [19]. This is consistent with mitochondrial
uncoupling from excess ROS formation and corroborates
the presented findings. However, the described lack of
excess lipid peroxidation in the heart muscle after chal-
lenge by MDR P. aeruginosa herein is in disagreement
with two recent publications. In the first publication in
mice [20], excess ROS formation was found in the myo-
cardium 48 hours after CLP. In the present study, animal
killing was done at 5 hours (that is, earlier than the
mouse CLP model), and this may explain the discre-
pancy. In the second publication, excess formation of
ROS was found in the heart tissue as early as 3 hours
after bacterial challenge. However, this was a completely
different model of sepsis induced after aspiration chal-
lenge with Streptococcus pneumoniae [21].
Infections by MDR bacteria emerge as a serious pro-
blem in the hospital environment. They colonize
patients after long-term hospital stay, and they are the
cause of severe sepsis after ICU admission. Available
choices for antimicrobial therapy become more and
more limited, creating major hurdles. Limitations of
management shed light on interventions on the host
response. Antioxidant supplementation against excess
formation of ROS and RNS belongs to these interven-
tions [22].
Animal sepsis models offer the advantage of well-
defined infection settings and of clear-cut approaches.
The human situation is far more difficult; comorbid
conditions play a pivotal role, and only indirect simula-
tions can be done. Trying to validate the generated ani-
mal data in human sepsis, it was decided that one
hospital-acquired infection by MDR gram-negative bac-
teria should be studied. To this end, a cohort of patients
with VAP by MDR gram-negative species was studied
[13]. This cohort proved to be an adequate equivalent of
clinical sepsis by MDR bacteria, because circulating
MDA did not differ in relation to the implicated bacter-
ial species.
Circulating MDA was correlated with the types of fail-
ing organs. Results indicated that MDA was particularly
elevated in specific organ failures compared with
patients with none organ failure corroborating the ani-
mal data for compartmentalization of lipid peroxidation.
In a recent study [7], concentrations of the lipid meta-
bolites F2-isoprostane and isoflurane were measured in
50 patients with severe sepsis. These metabolites were
considered an indirect index of lipid peroxidation. Mea-
sured concentrations were greater in patients who devel-
oped hepatic failure compared with those who did not.
Contrary to the presented clinical findings, F2-isopros-
tane and isoflurane were greater in the event of renal
failure. In the same study of 50 patients with severe sep-
sis [7], levels of lipid metabolites remained unchanged
in the event of ARDS and of CV failure. Many studies
have provided evidence for excess lipid formation in the
event of acute lung injury and of ARDS [23]. This is
probably related to the high infiltration of the lung by
neutrophils that overproduce ROS. Our study indicated
that ARDS ensuing in the absence of CV failure is
accompanied by excess lipid peroxidation. However,
when ARDS is accompanied by CV failure, excess circu-
lating MDA ceases to exist. The study of the levels of
F2-isoprostane and isoflurane in severe sepsis did not
study separately patients with ARDS without CV failure
from patients with both ARDS and CV failure.
Many of the conducted clinical studies on the forma-
tion of ROS in human sepsis have shown that excess
lipid peroxidation is an index of unfavorable outcome
[5,6,23]. Findings of the present study suggest that
kinetics of MDA in serum differ between survivors and
nonsurvivors, depending on the type of organ failure.
More precisely, MDA is increased over the disease
course of survivors of hepatic dysfunction and of ARDS.
On the contrary, it is decreased over the time course of
survivors of acute renal dysfunction. The results of the
current study do not provide mechanistic data to
explain the findings, and only assumptions can be made.
Regarding the increase of serum MDA within nonsurvi-
vors of acute renal dysfunction, it may be hypothesized
that although lipid peroxidation in not the principal
mechanism for acute renal dysfunction, it participates in
Figure 4 Oxidative burst of circulating neutrophils. Experimental
sepsis was induced in rats after the intraperitoneal injection of one
multidrug-resistant isolate of Pseudomonas aeruginosa. Five hours
after challenge (n = 6 per time), rats were killed, and oxidative burst
on neutrophils was measured as the expression of
dihydrorhodamine (DHR) on cell membranes after flow-cytometric
analysis. P value compared with sham-operated rats is shown.
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the progression toward unfavorable outcome. Further-
more, different patterns of the kinetics of serum MDA
are shown in survivors and nonsurvivors of CV failure
with and without ARDS. Taking into consideration the
respective patterns in patients only with ARDS, it may
be postulated that overall, serum MDA is elevated in
the event of ARDS; this is decreased on addition of CV
failure and further decreased in those only with CV
failure.
Animal sepsis with MDR P. aeruginosa was accompa-
nied by a defective oxidative burst of circulating neutro-
phils. However, tissue MDA of the spleen was increased.
These findings are in accordance with the decrease in
serum activity of myeloperoxidase described in patients
with septic shock [24]. It may thus be hypothesized that
in the event of severe sepsis and organ failures, circulat-
ing neutrophils are defective in efficient oxidative bursts
and phagocytosis, whereas these same functions are upre-
gulated in peripheral organs like the spleen and the lung.
The complementary findings between the described
animal model and human sepsis are highly indicative of
an existing compartmentalization of lipid peroxidation
in systemic infections with MDR gram-negative bacteria.
It should be underscored that such a study design is not
devoid of limitations. The major limitation is the time
course until the start of one organ failure, which is
determined by the investigators of an animal study, in
contrast to the clinical situation in which this is not
possible to be defined with precision. However, the
described compartmentalization may explain, at least in
part, the contradictory findings of clinical studies with
antioxidant supplementation in severe sepsis [23].
Results of the present study can be used to select the
populations of patients at severe sepsis that may benefit
Figure 5 Serum concentrations of MDA in patients with sepsis. Concentrations of malondialdehyde (MDA) were measured on the first day
of sepsis due to ventilator-associated pneumonia with multidrug-resistant gram-negative bacteria in 93 patients. Results are presented according
to the types of failing organs: (a) patients with hepatic dysfunction versus patients without any organ failure; (b) patients with ARDS versus
patients without any organ failure; (c) patients with ARDS and CV failure versus patients without any organ failure; (d) patients with CV failure
without ARDS versus patients without any organ failure; and (e) patients with acute renal dysfunction versus patients without any organ failure).
Circles denote outliers. P values reflect comparisons between patients without any organ failure and with the indicated organ failure. ARDS,
acute respiratory distress syndrome; CV, cardiovascular.
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from antioxidant agents, with emphasis on patients with
hospital-acquired sepsis with MDR gram-negative spe-
cies. Although it cannot be precluded that lipid peroxi-
dation may be stimulated in a similar mechanism by
gram-negative bacteria and by gram-positive cocci, the
present results are limited on gram-negative sepsis, par-
ticularly because gram-negative species emerged as the
main pathogens of the studied cohort.
Conclusions
These findings coming from an experimental infection
model that are confirmed from a patient cohort clearly
indicate that, during systemic infections, lipid peroxida-
tion is characterized by high compartmentalization. The
phenomenon is considerably upregulated in the event of
ARDS and hepatic dysfunction and downregulated in
the event of acute renal dysfunction.
Key messages
• High compartmentalization of lipid peroxidation
exists in experimental P. aeruginosa infection
Figure 6 Serum concentrations of MDA in patients with sepsis.
Concentrations of malondialdehyde (MDA) were measured on the
first day of sepsis due to ventilator-associated pneumonia with
multidrug-resistant gram-negative bacteria in 93 patients. Results are
presented according to the type of implicated pathogen. Circles
denote outliers, and asterisks denote extremes.
Figure 7 Follow-up measurements of MDA of serum in patients with sepsis. Concentrations of malondialdehyde (MDA) were measured for
7 consecutive days in patients with ventilator-associated pneumonia with multidrug-resistant gram-negative bacteria and sepsis. Results are
presented according to the type of failing organ: (a) patients with hepatic dysfunction; (b) only ARDS patients; (c) patients with ARDS and CV
failure; (d) patients with CV failure without ARDS; and (e) patients with acute renal dysfunction, and separately for survivors (S) and nonsurvivors
(NS). *P < 0.05 between S and NS.
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• Increased levels are found in liver, spleen, and
aorta, and decreased levels are found in kidney.
• Results are confirmed in a cohort of patients with
gram-negative sepsis
• Levels of MDA are increased in hepatic dysfunc-
tion and ARDS
• Levels of MDA are decreased in renal dysfunction
and remain unchanged in cardiovascular failure
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